435 related articles for article (PubMed ID: 7542418)
1. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing.
Raux H; Coulon P; Lafay F; Flamand A
Virology; 1995 Jul; 210(2):400-8. PubMed ID: 7542418
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of rabies virus neutralization.
Flamand A; Raux H; Gaudin Y; Ruigrok RW
Virology; 1993 May; 194(1):302-13. PubMed ID: 7683158
[TBL] [Abstract][Full Text] [Related]
3. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ
Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology.
Zhao XL; Yin J; Chen WQ; Jiang M; Yang G; Yang ZH
Microbiol Immunol; 2008 Feb; 52(2):89-93. PubMed ID: 18380806
[TBL] [Abstract][Full Text] [Related]
5. Characterization of epitopes on the rabies virus glycoprotein by selection and analysis of escape mutants.
Fallahi F; Wandeler AI; Nadin-Davis SA
Virus Res; 2016 Jul; 220():161-71. PubMed ID: 27132040
[TBL] [Abstract][Full Text] [Related]
6. Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies.
Liu DX; Gompels UA; Foa-Tomasi L; Campadelli-Fiume G
Virology; 1993 Nov; 197(1):12-22. PubMed ID: 7692666
[TBL] [Abstract][Full Text] [Related]
7. Identification of amino acids controlling the low-pH-induced conformational change of rabies virus glycoprotein.
Gaudin Y; Raux H; Flamand A; Ruigrok RW
J Virol; 1996 Nov; 70(11):7371-8. PubMed ID: 8892855
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
Gromowski GD; Barrett AD
Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
[TBL] [Abstract][Full Text] [Related]
9. Common and different antigenic properties of the rabies virus glycoprotein of strains SAD-Vnukovo and Pitman-Moore.
Máciková I; Dedek L; Vrzal V; Kontseková E; Kontsek P; Ciampor F; Novák M
Acta Virol; 1992 Dec; 36(6):541-50. PubMed ID: 1284868
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus.
Giammarioli AM; Mackow ER; Fiore L; Greenberg HB; Ruggeri FM
Virology; 1996 Nov; 225(1):97-110. PubMed ID: 8918537
[TBL] [Abstract][Full Text] [Related]
11. Characterization of epitopes for virus-neutralizing monoclonal antibodies to Ross River virus E2 using phage-displayed random peptide libraries.
Davies JM; Cai YP; Weir RC; Rowley MJ
Virology; 2000 Sep; 275(1):67-76. PubMed ID: 11017788
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
13. Further studies on the mechanism of rabies virus neutralization by a viral glycoprotein-specific monoclonal antibody, #1-46-12.
Irie T; Kawai A
Microbiol Immunol; 2005; 49(8):721-31. PubMed ID: 16113501
[TBL] [Abstract][Full Text] [Related]
14. Mapping of the low pH-sensitive conformational epitope of rabies virus glycoprotein recognized by a monoclonal antibody #1-30-44.
Kankanamge PJ; Irie T; Mannen K; Tochikura TS; Kawai A
Microbiol Immunol; 2003; 47(7):507-19. PubMed ID: 12953844
[TBL] [Abstract][Full Text] [Related]
15. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein.
Balasuriya UB; Patton JF; Rossitto PV; Timoney PJ; McCollum WH; MacLachlan NJ
Virology; 1997 May; 232(1):114-28. PubMed ID: 9185595
[TBL] [Abstract][Full Text] [Related]
16. Studies on the escape mutants of rabies virus which are resistant to neutralization by a highly conserved conformational epitope-specific monoclonal antibody #1-46-12.
Irie T; Matsuda Y; Honda Y; Morimoto K; Kawai A
Microbiol Immunol; 2002; 46(7):449-61. PubMed ID: 12222931
[TBL] [Abstract][Full Text] [Related]
17. Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.
Bakker AB; Marissen WE; Kramer RA; Rice AB; Weldon WC; Niezgoda M; Hanlon CA; Thijsse S; Backus HH; de Kruif J; Dietzschold B; Rupprecht CE; Goudsmit J
J Virol; 2005 Jul; 79(14):9062-8. PubMed ID: 15994800
[TBL] [Abstract][Full Text] [Related]
18. Characterization of epitopes for neutralizing monoclonal antibodies to classical swine fever virus E2 and Erns using phage-displayed random peptide library.
Zhang F; Yu M; Weiland E; Morrissy C; Zhang N; Westbury H; Wang LF
Arch Virol; 2006 Jan; 151(1):37-54. PubMed ID: 16132176
[TBL] [Abstract][Full Text] [Related]
19. Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus.
Balasuriya UB; Maclachlan NJ; De Vries AA; Rossitto PV; Rottier PJ
Virology; 1995 Mar; 207(2):518-27. PubMed ID: 7533965
[TBL] [Abstract][Full Text] [Related]
20. Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides.
Chassot S; Lambert V; Kay A; Godinot C; Roux B; Trepo C; Cova L
Virology; 1993 Jan; 192(1):217-23. PubMed ID: 7685963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
